A novel dendritic cell subset involved in tumor immunosurveillance (original) (raw)

T and NK cells: two sides of tumor immunoevasion

Maria Benevolo, Elisa Tremante

Journal of Translational Medicine, 2013

View PDFchevron_right

NK cells and ILCs in tumor immunotherapy

Simona Sivori

Molecular Aspects of Medicine, 2021

View PDFchevron_right

Intratumoral hu14.18-IL-2 (IC) Induces Local and Systemic Antitumor Effects That Involve Both Activated T and NK Cells As Well As Enhanced IC Retention

Alexander Rakhmilevich

The Journal of Immunology, 2012

View PDFchevron_right

IL-15 AND TYPE I INTERFERON ARE REQUIRED FOR ACTIVATION OF TUMORICIDAL NK CELLS BY VIRUS-INFECTED DENDRITIC CELLS

Jeanette Boudreau

Cancer Research, 2011

View PDFchevron_right

Melanoma immunoediting by NK cells

Gabriella Pietra

OncoImmunology, 2012

View PDFchevron_right

Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors

Doriana Fruci

Frontiers in Immunology

View PDFchevron_right

Immunosurveillance and immunotherapy of tumors by innate immune cells

Alexandre Iannello

Current Opinion in Immunology, 2016

View PDFchevron_right

Enhanced Antitumor Immunity Elicited by Dendritic Cell Vaccines Is a Result of Their Ability to Engage Both CTL and IFNγ-Producing NK Cells

Jeanette Boudreau

Molecular …, 2007

View PDFchevron_right

The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ

Carlos Adalberto Perez Alfaro

International Journal of Cancer, 2007

View PDFchevron_right

The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN

Amanda Jamieson

International Journal of Cancer, 2007

View PDFchevron_right

Helper role of NK cells during the induction of anticancer responses by dendritic cells

John Kirkwood

Molecular Immunology, 2005

View PDFchevron_right

Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors

Natalio Garbi

Journal of Experimental Medicine, 2012

View PDFchevron_right

Early activation and interferon-γ production of tumor-infiltrating mature CD27high natural killer cells

Yoichiro Iwakura

Cancer Science, 2011

View PDFchevron_right

Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells

Michael Idowu

Journal of leukocyte biology, 2016

View PDFchevron_right

NK1.1+ Cells and CD8+ T Cells Mediate the Antitumor Activity of Cl-IB-MECA in a Mouse Melanoma Model

Silvana Morello

Neoplasia, 2011

View PDFchevron_right

Combating Cancer With Tumor Immunotherapy

Ashish Runthala

e Journal of Biological Sciences, 1 (1), 11-22., 2009

View PDFchevron_right

Editorial: Modulation of Human Immune Parameters by Anticancer Therapies

Frank Preijers

Frontiers in Immunology, 2020

View PDFchevron_right

Mechanism of tumor cells escaping from immune surveillance of NK cells

Shuzhe Ding

Immunopharmacology and Immunotoxicology, 2020

View PDFchevron_right

Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors

U. Sahin

Cancer Immunology, Immunotherapy, 1996

View PDFchevron_right

IFN-γ-Producing Human Invariant NKT Cells Promote Tumor-Associated Antigen-Specific Cytotoxic T Cell Responses

Johan Molling

The Journal of Immunology, 2008

View PDFchevron_right

Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells

Mark Smyth

Journal of Experimental Medicine, 2000

View PDFchevron_right

Differential internalization of hu14.18-IL2 immunocytokine by NK and tumor cell: impact on conjugation, cytotoxicity, and targeting

Jennifer Gubbels

Journal of Leukocyte Biology, 2011

View PDFchevron_right

Editorial: The Natural Killer Cell Interactome in the Tumor Microenvironment: Basic Concepts and Clinical Application

Martín Villalba

Frontiers in Immunology, 2020

View PDFchevron_right

From www.bloodjournal.org by guest on March 21, 2015. For personal use only. IMMUNOBIOLOGY Induction of tumor NK-cell immunity by anti-CD69 antibody therapy

pilar lauzurica

View PDFchevron_right

Recognition of tumors by the innate immune system and natural killer cells

Alexandre Iannello

Advances in immunology, 2014

View PDFchevron_right

Characterizing the anti-tumor function of adoptively transferred NK cells in vivo

Phillip Darcy

Cancer Immunology, Immunotherapy, 2010

View PDFchevron_right